Crestline Management, LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Crestline Management, LP held in its portfolio 3 assets valued at $53,326,374 (i.e. $53.33M).

The most valuable assets in the portfolio included: DENALI THERAPEUTICS INC ($46.41M), SANA BIOTECHNOLOGY INC ($4.97M), and 8X8 INC NEW ($1.95M).

The chart below shows the top 3 valuable assets, and the table below shows the top 3 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Crestline Management, LP Portfolio

DENALI THERAPEUTICS INC

SANA BIOTECHNOLOGY INC

8X8 INC NEW

Crestline Management, LP - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
DENALI THERAPEUTICS INC	2810732	46405185	COM
SANA BIOTECHNOLOGY INC	1220937	4969214	COM
8X8 INC NEW	990580	1951975	COM